Last reviewed · How we verify
NCT05756023
IVF\ICSI Outcome in Women With Polycystic Ovary Syndrome
NA trial testing the pregnancy rate at IVF / ICSI cycles in PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries in 156 participants. Currently enrolling.
1 December 2026
Quick facts
| Lead sponsor | Egymedicalpedia |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | diagnostic |
| Enrollment | 156 |
| Start date | 1 June 2023 |
| Primary completion | 1 December 2026 |
| Estimated completion | 15 December 2026 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- the pregnancy rate at IVF / ICSI cycles
Conditions studied
- PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries — all drugs for PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries →
Sponsor
Egymedicalpedia — full company profile →
Who can join
Adults 20 to 35, female only, with PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Polycystic ovarian syndrome (PCOS) occurs in 5% to 10% of all women of reproductive age and 50% of women who present with sub-fertility due to anovulatory infertility . Clear diagnostic criteria for this condition were identified at the consensus meeting of the European Society of Human Reproduction and Embryology and the American Society for Reproductive Medicine .
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05756023
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries
Currently open trials in the same condition.
- NCT07182526 — Effects of Adding Quercetin or Alpha Lipoic Acid to Usual Care on Symptoms and Blood Markers in Iraqi Women With Polycys · Phase 2 · recruiting
- NCT05734287 — The Frequency of Polycystic Ovary Syndrome Among Young Reproductive Females Presenting With Hyperandrogenism: a Mixed Co · recruiting
- NCT06050265 — Glucose Evaluation Through Continuous Glucose Monitors in Polycystic Ovary Syndrome · NA · active not recruiting
- NCT05819853 — Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary Syndrome · Phase 3 · recruiting
- NCT06041204 — Best Treatment for Women With Both (Polycystic Ovary Syndrome) PCOS and Subclinical Hypothyroidism · NA · recruiting
Other Egymedicalpedia trials
Trials by the same sponsor.
- NCT06590818 — The Effect of Body Mass Index on Short-term Results of HTO · NA · recruiting
- NCT06583811 — Remifentanil and Remimazolam to Limit Patient Movement · NA · recruiting
- NCT06522984 — Fractional Erbium YAG Laser vs Intradermal and Systemic Tranexamic Acid · NA · recruiting
- NCT06370078 — Effect of Early Administration of Albumin 20% Versus Crystalloid · NA · recruiting
- NCT06370221 — The Effect of Psoriatic Arthritis on Female Sexual Dysfunction · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05756023 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Egymedicalpedia
- Last refreshed: 19 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05756023.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing